Does Insurance Pay for Stem Cell Injections? 2026 Guide

For most patients, the short answer is no. Standard health insurance plans, including Medicare, generally do not cover stem cell therapy for orthopedic, degenerative, or aesthetic conditions. Insurers label these procedures experimental (American Academy of Orthopaedic Surgeons, n.d.-b).

The narrow exception is FDA-approved hematopoietic stem cell transplants. These are used for certain blood cancers and immune disorders. Plans usually cover them when they are medically necessary (U.S. Food and Drug Administration, 2020).

Are you looking at regenerative options for joint pain, an old injury, or general wellness? Plan on paying out of pocket.

Understanding why, and how much, can help you make a more informed decision.

This guide covers three questions:

• What do stem cell procedures cost?
• When may a therapy be covered by insurance?
• How do the options vary by the type of stem cell product?

Why Insurers Call Stem Cell Therapy "Experimental"

Coverage decisions are tied closely to two things: FDA approval status, and peer-reviewed clinical evidence.

Right now, only one class of stem cell product is approved for use in the United States. The U.S. Food and Drug Administration has approved blood-forming (hematopoietic) stem cells that come from umbilical cord blood.

These are approved specifically for disorders that affect blood production (U.S. Food and Drug Administration, 2020).

No stem cell product is FDA-approved for any of the following (U.S. Food and Drug Administration, 2020):

• Orthopedic conditions, such as osteoarthritis, tendon injuries, or back pain
• Neurological conditions
• Cardiovascular conditions
• Autoimmune conditions

Most regenerative orthopedic procedures fall outside that narrow approval. Orthopedic and insurance industry sources still call stem cell therapy for joint and soft-tissue conditions investigational. That holds even when the cells come from the patient's own body (American Academy of Orthopaedic Surgeons, n.d.-b).

Insurers use "experimental" or "investigational" labels for one reason. The labels let them exclude coverage until stronger large-scale trial data exists.

The Rare Cases Insurance Does Cover

Two very different things both get called "stem cell therapy." It helps to keep them apart. Hematopoietic stem cell transplants are sometimes called bone marrow transplants. Doctors have used them for decades in patients with leukemia, lymphoma, and certain inherited metabolic and immune conditions.

This category is generally covered by insurance and Medicare when medically necessary (Mayo Clinic Staff, 2026).

That is a very different thing from the injectable, orthopedic, or aesthetic stem cell and regenerative procedures. Those are what most patients mean when they search for cost information. Insurers routinely decline to pay for them (American Academy of Orthopaedic Surgeons, n.d.-a).

What Drives the Out-of-Pocket Cost?

Pricing is not standardized or regulated the way it is for insurance-covered procedures. So cost varies a lot by clinic, provider, and treatment plan.

Research on the direct-to-consumer regenerative medicine market found thousands of U.S. clinics offering these interventions. Reported prices reached as high as $25,000 in that research. The figure depends on the condition and the product used (Arthurs et al., 2022).

Several factors typically influence what you'll be quoted:

• The source and type of cells used (a patient's own bone marrow or adipose tissue versus other cell-based products)
• The number of injections or treatment sessions recommended
• Whether the treatment targets one joint or multiple areas
• Whether it's combined with complementary therapies, such as platelet-rich plasma or imaging guidance
• The clinic's location, overhead, and the provider's experience level

Orthopedic specialists note that "costs vary for each type of biologic and for each doctor or facility." So they advise you to review itemized pricing with your provider. Do not lean on advertised starting prices (American Academy of Orthopaedic Surgeons, n.d.-a).

How to Evaluate a Clinic Before You Pay

Before committing to any regenerative procedure, it's worth doing some homework:

• Confirm whether the specific product or protocol is part of an FDA-approved clinical trial. That status affects the strength of the evidence. In rare cases it also affects your coverage options (American Academy of Orthopaedic Surgeons, n.d.-a).
• Call your insurer and ask about your own plan and condition. Do not rely on a clinic's marketing claims. Coverage can vary even for FDA-approved orthobiologic products (American Academy of Orthopaedic Surgeons, n.d.-a).
• Ask any provider what published evidence backs their protocol. Research quality and study design vary widely across direct-to-consumer stem cell offerings (Arthurs et al., 2022).

What This Means If You're Considering Treatment

Most patients looking at regenerative or stem cell options should plan their budget as if insurance will not contribute. That holds for joint pain, sports injuries, and general wellness.

Then treat any partial payment as a pleasant surprise, not as something to count on.

Some patients offset the cost in one of these ways:

• HSA or FSA funds
• Financing plans offered by clinics
• Comparing several consultations before choosing a provider

Whatever you decide, always talk with your provider about realistic expectations. Results and recovery vary from person to person.

No regenerative procedure outside an approved clinical trial is guaranteed to resolve or reverse a specific condition (U.S. Food and Drug Administration, 2020).

Frequently Asked Questions

Does Medicare cover stem cell therapy for knee or joint pain?

Generally, no. Medicare covers FDA-approved hematopoietic stem cell transplants for certain cancers and blood disorders. It does not typically cover orthopedic stem cell injections for joint pain or osteoarthritis. Those are considered investigational (American Academy of Orthopaedic Surgeons, n.d.-b).

What stem cell products are actually FDA-approved?

Only blood-forming stem cell products from umbilical cord blood are FDA-approved right now. They are approved only for disorders affecting blood production. No stem cell product is FDA-approved for orthopedic, cosmetic, neurological, or autoimmune use outside a clinical trial (U.S. Food and Drug Administration, 2020).

Why won't my insurance company pay even if my doctor recommends it?

Insurers look at two things: strong clinical trial evidence, and FDA approval for the specific condition in question.

Most regenerative orthopedic procedures do not yet meet that bar. So insurers label them experimental, no matter what patient stories suggest (American Academy of Orthopaedic Surgeons, n.d.-b).

Can I use an HSA or FSA to pay for stem cell therapy?

Many patients do use HSA or FSA funds for regenerative procedures. Whether you can depends on your plan administrator. It also depends on whether the procedure is deemed a qualified medical expense. Check with your plan administrator before scheduling.

Is a cheaper clinic ever a red flag?

Price alone is not a reliable sign of quality or safety. Ask about these four things instead of choosing on cost alone (Arthurs et al., 2022):

• FDA trial status
• Cell sourcing
• Provider credentials
• Published outcomes data

Ready to Talk Through Your Options?

Maybe you are weighing regenerative medicine for an orthopedic condition. Maybe you just want to know what a realistic budget looks like. The team at PrimeCell Regenerative can walk you through your options and discuss candidacy. They can also help you understand costs before you commit to anything.

Reach out to schedule a consultation.

References

American Academy of Orthopaedic Surgeons. (n.d.-a). Orthobiologics (regenerative medicine) FAQ. OrthoInfo. https://orthoinfo.aaos.org/en/treatment/orthobiologics-faq/

American Academy of Orthopaedic Surgeons. (n.d.-b). Use of stem cells in orthopaedics. OrthoInfo. https://orthoinfo.aaos.org/en/treatment/use-of-stem-cells-in-orthopaedics/

Arthurs, J. R., Martin Lillie, C. M., & Shapiro, S. A. (2022). The direct to consumer stem cell market and the role of primary care providers in correcting misinformation. Journal of Primary Care & Community Health, 13. https://doi.org/10.1177/21501319221121460

Mayo Clinic Staff. (2026, January 21). Stem cells: What they are and what they do. Mayo Clinic. https://www.mayoclinic.org/tests-procedures/bone-marrow-transplant/in-depth/stem-cells/art-20048117

U.S. Food and Drug Administration. (2020, July 22). Consumer alert on regenerative medicine products including stem cells and exosomes. https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/consumer-alert-regenerative-medicine-products-including-stem-cells-and-exosomes

This article is for educational purposes only and does not constitute medical advice. Most stem cell and regenerative therapies offered outside FDA-approved clinical trials are investigational and are not FDA-approved to cure, treat, or prevent any specific disease; individual results and outcomes vary.

Please consult a licensed physician or provider to discuss whether any regenerative procedure is appropriate for your condition before proceeding. Medically reviewed by Kenny Chantasi, DO.

Related reading

• Stem Cell Cost: What Is the Average Price of Therapy?
• Does Insurance Cover Hormone Replacement Therapy?
• Does Medicare Cover Regenerative Medicine?
• How Much Does Peptide Therapy Cost?

More questions answered on the PrimeCell patient blog, or see frequently asked questions.

Related services at PrimeCell

PrimeCell is a physician-led practice in Orlando. Candidacy for any procedure is determined at an in-person evaluation.